Breaking News Instant updates and real-time market news.

FL

Foot Locker

$46.10

-2.69 (-5.51%)

, NKE

Nike

$71.13

-1.39 (-1.92%)

09:30
11/21/18
11/21
09:30
11/21/18
09:30

Foot Locker price target raised to $63 from $56 at Credit Suisse

Credit Suisse analyst Michael Binetti raised his price target for Foot Locker (FL) to $63 from $56 following quarterly results as he believes the company proved out the accelerating same-store sales story. The analyst thinks Q3 goes a long way to proving Foot Locker can comp alongside Nike's (NKE) DTC aspirations. Binetti reiterates an Outperform rating on Foot Locker's shares.

FL

Foot Locker

$46.10

-2.69 (-5.51%)

NKE

Nike

$71.13

-1.39 (-1.92%)

  • 20

    Dec

FL Foot Locker
$46.10

-2.69 (-5.51%)

11/21/18
LEHM
11/21/18
NO CHANGE
Target $70
LEHM
Overweight
Barclays remains bullish on shares of Foot Locker
In a post-earnings research note titled "Good Things Come to Those Who Wait," Barclays analyst Matthew McClintock says he remains bullish on shares of Foot Locker. The company is "clearly on the path to acceleration" that management has referred to all year, which indicates 2019 "could prove to be a return to normalcy," McClintock tells investors. He increased his estimates and keeps an Overweight rating on Foot Locker with a $70 price target.
11/21/18
WELS
11/21/18
NO CHANGE
Target $64
WELS
Outperform
Foot Locker price target raised to $64 from $58 at Wells Fargo
Wells Fargo analyst Tom Nikic raised his price target for Foot Locker (FL) to $64 from $58 and reiterated an Outperform rating on the shares. The analyst believes Foot Locker's turnaround story continues to pick up steam, as he thinks the Q3 print alleviated many of the concerns that have weighed on the shares this year. Nikic continues to view Foot Locker as a "very compelling turnaround story," driven by improving product flows, strong relationships with their key vendors such as Nike (NKE), a capable management team that has shown an ability to quickly adapt to changing market conditions, and a stock that is still fairly inexpensive.
11/21/18
JEFF
11/21/18
NO CHANGE
Target $62
JEFF
Buy
Jefferies says Foot Locker 'back on its feet,' boosts target to $62
Jefferies analyst Janine Stichter proclaims Foot Locker is "back on its feet" after the company reported upside in Q3 to both sales and margins. The analyst sees a case for both earnings upside and multiple expansion as "confidence in the top-line sustainability is restored." She raised her price target for Foot Locker shares to $62 from $60 and keeps a Buy rating on the name Foot Locker remains Stichter's favorite way to play Nike's (NKE) resurgence in North America.
11/21/18
ADAM
11/21/18
NO CHANGE
Target $64
ADAM
Buy
Foot Locker recovery thesis playing out, says Canaccord
Canaccord analyst Camilo Lyon noted Foot Locker reported solid Q3 results and said the beat was high quality. He was particularly pleased with the inflection in footwear and Europe as it benefited from the breadth and depth of on-trend platforms that resulted in an improving inventory mix. Lyon believes the results show his recovery thesis is playing out. He reiterated his Buy rating and raised his price target to $64 from $63 on Foot Locker shares.
NKE Nike
$71.13

-1.39 (-1.92%)

10/30/18
ARGS
10/30/18
DOWNGRADE
ARGS
Flex downgraded to Hold from Buy at Argus
Argus analyst Jim Kelleher downgraded Flex (FLEX) to Hold after its "disappointing" Q2 results and "weak" Q3 guidance revealed last week. The analyst also cites the expected impact from the "shutdown of Mexican operations with key customer Nike (NKE), which he expects to be fully unwound", as well as the retirement of the company CEO Mike McNamara who had presided over the company's business expansion. Kelleher adds that the loss of Nike compounds lost business from other high-profile clients, including toymaker Lego as well as numerous mobile device makers.
11/14/18
LEHM
11/14/18
NO CHANGE
Target $70
LEHM
Overweight
Foot Locker well positioned to meet this quarter's guidance, says Barclays
Barclays analyst Matthew McClintock believes Foot Locker (FL) is well positioned to meet guidance this quarter with further acceleration into Q4 and beyond. The analyst, who acknowledges that comp expectations are likely for flat to slightly negative, says Nike's (NKE) recently reported wholesale revenue growth of 5.2% is a "strong indication of an inflection" in Foot Locker's business. The analyst is estimating a 2.6%, above the 1.8% consensus, increase in comp store sales for Foot Locker and earnings per share of 94c, or a 3c beat. He keeps an Overweight rating on the shares with a $70 price target.

TODAY'S FREE FLY STORIES

WMB

Williams

$27.80

0.24 (0.87%)

16:19
03/18/19
03/18
16:19
03/18/19
16:19
Hot Stocks
Williams, CPPIB to form $3.8B strategic JV partnership »

Williams announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CW

Curtiss-Wright

$115.19

2.99 (2.66%)

16:18
03/18/19
03/18
16:18
03/18/19
16:18
Hot Stocks
Curtiss-Wright acquires Tactical Communications Group for $50M »

Curtiss-Wright announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 26

    Mar

  • 27

    Mar

UVSP

Univest

$25.82

-0.17 (-0.65%)

16:18
03/18/19
03/18
16:18
03/18/19
16:18
Hot Stocks
Univest CFO Roger Deacon to retire »

Univest Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Apr

CNO

CNO Financial

$17.01

0.18 (1.07%)

16:17
03/18/19
03/18
16:17
03/18/19
16:17
Hot Stocks
CNO Financial names Paul McDonough CFO, Rocco Tarasi as Chief Marketing Officer »

CNO Financial named Paul…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 10

    May

TORC

ResTORbio

$8.97

0.27 (3.10%)

16:17
03/18/19
03/18
16:17
03/18/19
16:17
Syndicate
ResTORbio files to sell $50M in common stock »

BofA Merrill Lynch, SVB…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WBT

Welbilt

$15.98

0.27 (1.72%)

, LL

Lumber Liquidators

$9.81

-0.4 (-3.92%)

16:17
03/18/19
03/18
16:17
03/18/19
16:17
Hot Stocks
Welbilt names Martin D. Agard CFO »

Welbilt, Inc. (WBT)…

WBT

Welbilt

$15.98

0.27 (1.72%)

LL

Lumber Liquidators

$9.81

-0.4 (-3.92%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 20

    Mar

  • 26

    Apr

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
03/18/19
03/18
16:17
03/18/19
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EOLS

Evolus

$23.80

-1.02 (-4.11%)

16:16
03/18/19
03/18
16:16
03/18/19
16:16
Earnings
Evolus reports Q4 EPS (46c), consensus (55c) »

Total cash was $93.2M as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

NVAX

Novavax

$0.52

0.0122 (2.38%)

16:16
03/18/19
03/18
16:16
03/18/19
16:16
Earnings
Novavax reports Q4 EPS (13c), consensus (12c) »

Reports Q4 revenue $6.1M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 19

    Mar

IBP

Installed Building Products

$43.96

-0.42 (-0.95%)

16:16
03/18/19
03/18
16:16
03/18/19
16:16
Hot Stocks
Installed Building Products acquires 1st State Insulation, terms not stated »

Installed Building…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

  • 27

    Mar

  • 28

    Mar

  • 18

    Jun

GSL

Global Ship Lease

$0.82

0.0237 (2.98%)

16:16
03/18/19
03/18
16:16
03/18/19
16:16
Hot Stocks
Global Ship Lease announces new long-term charter agreement »

Global Ship Lease has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
03/18/19
03/18
16:16
03/18/19
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGE

Tallgrass Energy

$24.23

0.18 (0.75%)

16:15
03/18/19
03/18
16:15
03/18/19
16:15
Hot Stocks
Tallgrass Energy names Bill Moler president »

Tallgrass Energy, LP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWO

Two Harbors

$14.26

0.07 (0.49%)

16:15
03/18/19
03/18
16:15
03/18/19
16:15
Syndicate
Two Harbors files to sell 18M shares of common stock »

Credit Suisse, J.P.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 16

    May

PFSW

PFSweb

$6.37

0.29 (4.77%)

16:14
03/18/19
03/18
16:14
03/18/19
16:14
Earnings
PFSweb sees FY19 SFE revenue increase in low-single digits »

PFSweb expects 2019 SFE…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 27

    Mar

  • 28

    Mar

HQY

HealthEquity

$82.86

0.76 (0.93%)

16:14
03/18/19
03/18
16:14
03/18/19
16:14
Earnings
HealthEquity sees FY20 EPS 1.23-$1.29, consensus $1.31 »

Sees FY20 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 19

    Mar

  • 21

    Mar

  • 17

    Apr

PFSW

PFSweb

$6.29

0.21 (3.45%)

16:13
03/18/19
03/18
16:13
03/18/19
16:13
Earnings
PFSweb client bankruptcy to have negative impact on FY19 revenue »

One of PFSweb's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 27

    Mar

  • 28

    Mar

HQY

HealthEquity

$82.92

0.82 (1.00%)

16:12
03/18/19
03/18
16:12
03/18/19
16:12
Hot Stocks
HealthEquity reports Q4 EPS 27c, consensus 22c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 19

    Mar

  • 21

    Mar

  • 17

    Apr

RMAX

RE/MAX Holdings

$39.09

1.07 (2.81%)

, RDFN

Redfin

$18.50

0.04 (0.22%)

16:12
03/18/19
03/18
16:12
03/18/19
16:12
Hot Stocks
RE/MAX Holdings, Redfin announce exclusive referral relationship »

RE/MAX Holdings (RMAX)…

RMAX

RE/MAX Holdings

$39.09

1.07 (2.81%)

RDFN

Redfin

$18.50

0.04 (0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 26

    Mar

  • 27

    Mar

FWRD

Forward Air

$64.27

0.66 (1.04%)

16:11
03/18/19
03/18
16:11
03/18/19
16:11
Hot Stocks
Forward Air to acquire FSA Logistix »

Forward Air Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFSW

PFSweb

$6.35

0.27 (4.44%)

16:11
03/18/19
03/18
16:11
03/18/19
16:11
Earnings
PFSweb reports Q4 EPS 17c, may not compare to consensus 24c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 27

    Mar

  • 28

    Mar

ICAD

iCAD

$4.44

-0.02 (-0.45%)

16:10
03/18/19
03/18
16:10
03/18/19
16:10
Earnings
iCAD reports Q4 EPS (20c), two-estimate consensus (10c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

VERU

Veru

$1.44

-0.05 (-3.36%)

16:10
03/18/19
03/18
16:10
03/18/19
16:10
Initiation
Veru initiated  »

Veru initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 26

    Mar

CYAD

Celyad

$21.35

(0.00%)

16:10
03/18/19
03/18
16:10
03/18/19
16:10
Hot Stocks
Celyad provides update on CYAD-01 at R&D Day »

Celyad presented at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 19

    Mar

  • 20

    Mar

  • 04

    Apr

  • 09

    Apr

CRBP

Corbus Pharmaceuticals

$6.90

0.18 (2.68%)

16:10
03/18/19
03/18
16:10
03/18/19
16:10
Initiation
Corbus Pharmaceuticals initiated  »

Corbus Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.